Transforming Growth Factor Beta 1 (TGF-β1) is a multifunctional cytokine playing a pivotal role in regulating a wide range of cellular processes, including cell growth, differentiation, apoptosis, and immune responses. As a member of the Transforming Growth Factor Beta superfamily of cytokines, TGF-β1 is particularly noted for its dual role in both promoting and inhibiting tumor formation. In normal physiological conditions, TGF-β1 functions as a critical regulator of tissue homeostasis, exerting potent anti-inflammatory and immunosuppressive effects. It helps maintain the balance in the immune system and prevents autoimmune responses. However, in the context of cancer, TGF-β1 has a more complex role. Initially, it acts as a tumor suppressor by inhibiting cell proliferation and inducing apoptosis. But paradoxically, in the later stages of cancer, it can promote tumor progression and metastasis by inducing epithelial-to-mesenchymal transition (EMT), angiogenesis, and immune evasion. Furthermore, TGF-β1 is involved in fibrosis and wound healing, where it stimulates the deposition of extracellular matrix components. Aberrant regulation or expression of TGF-β1 is linked to various pathological conditions, including fibrotic diseases, cardiovascular diseases, and a spectrum of cancer types. Consequently, TGF-β1 serves as a crucial biomarker and a therapeutic target, with efforts being directed towards developing TGF-β1 inhibitors for treating cancer and other diseases characterized by its dysregulation. The complexity of TGF-β1's functions underscores its significance in cellular biology and disease pathogenesis, making it a focus of extensive research in the biomedical field.
Every lab result you’ve ever had, charted and explained.
Healthmatters is a tracker for your lab results. Upload a report from any lab, any country — every marker charted and explained.
Start with my report →All our content is backed by peer-reviewed studies, academic research, and trusted medical sources. We’re committed to accuracy and transparency — see our editorial policy for details.